Dr. Castle on Minimally Invasive Surgical Approaches in RCC
Erik P. Castle, MD, discusses minimally invasive surgical approaches in renal cell carcinoma.
Dr. Castle on Staging Modalities for Men With High-Risk Prostate Cancer
Erik P. Castle, MD, professor of urology, Mayo Clinic, discusses traditional imaging modalities and newer counterparts that are used to detect prostate cancer.
Dr. Castle on Adjuvant Versus Early Salvage Therapy in Prostate Cancer
Erik P. Castle, MD, professor of urology, Mayo Clinic, discusses the use of adjuvant versus early salvage therapy in patients with prostate cancer, citing his own preference for early salvage therapy.
Currently Available Treatment Options for Patients With R/R DLBCL
Overview of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)
Both Gastric and Breast HER2 Scoring Algorithms Applicable in mCRC Testing
Encorafenib Plus Cetuximab and Chemotherapy Demonstrates Safety, Efficacy in BRAF V600E–Mutant mCRC
2 Clarke Drive Cranbury, NJ 08512